evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract
18973,GENE_BACKGROUND,,"The SPRED1 gene encodes a member of the Sprouty family of proteins. SPRED1 is a negative regulator of the MAP-kinase (MAPK) pathway (PMID: 15683364, 21364986). The mechanism by which SPRED1 inhibits MAPK signaling involves NF1 (neurofibromatosis type 1), which, upon interaction with SPRED1, localizes to the plasma membrane and facilitates RAS inactivation (PMID: 22751498, 26635368). Overexpression of SPRED1 in a hepatocellular carcinoma model leads to a decrease in cell motility and an increase in the expression of metalloproteinases, which are involved in invasion and metastasis (PMID: 16652141). SPRED1 is rarely mutated in cancers (cBioPortal, MSKCC, Dec. 2016). However, germline loss-of-function mutations in SPRED1 are the cause of Legius syndrome, a familial disorder with neurofibromatosis-like features (PMID: 24334617, 17704776, 19366998).",,2017-03-29,,161742,SPRED1,sprouty related EVH1 domain containing 1,False,ENST00000299084,NM_152594.2,spred-1,NFLS,hSpred1,PPP1R147,False,17704776,Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.,Nature genetics,2018-09-01T20:07:00,39,9,1120-6,Brems H et al,,,0001-09-01,,24334617,"Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.",The Keio journal of medicine,2013,62,4,107-12,Brems H et al,,,Brems H et al. The Keio journal of medicine. 2013;62(4)107-12.,,19366998,SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.,Journal of medical genetics,2018-07-01T20:09:00,46,7,425-30,Pasmant E et al,doi: 10.1136/jmg.2008.065243,,0001-07-01,,16652141,"Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.",Oncogene,2018-10-05T20:06:00,25,45,6056-66,Yoshida T et al,,,0001-10-05,,22751498,A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.,Genes &amp; development,2018-07-01T20:12:00,26,13,1421-6,Stowe IB et al,doi: 10.1101/gad.190876.112,,0001-07-01,,21364986,Sprouty2 and Spred1-2 proteins inhibit the activation of the ERK pathway elicited by cyclopentenone prostanoids.,PloS one,2018-02-22T20:11:00,6,2,e16787,García-Domínguez CA et al,doi: 10.1371/journal.pone.0016787,,0001-02-22,,26635368,"Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.",The Journal of biological chemistry,2018-02-12T20:16:00,291,7,3124-34,Hirata Y et al,doi: 10.1074/jbc.M115.703710,,0001-02-12,,15683364,Distinct requirements for the Sprouty domain for functional activity of Spred proteins.,The Biochemical journal,2018-06-01T20:05:00,388,Pt 2,445-54,King JA et al,,,0001-06-01,
18972,GENE_SUMMARY,,"SPRED1, a negative regulator of the MAP-kinase pathway, is mutated at low frequencies in various cancers.",,2017-03-29,,161742,SPRED1,sprouty related EVH1 domain containing 1,False,ENST00000299084,NM_152594.2,spred-1,NFLS,hSpred1,PPP1R147,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
